Alisa Valdes was one of the first case studies for Todos. She was supplied with plenty of Tollovid. She was taking the 5-day dosing back to back and posted 3-4 weeks of remarkable improvements, along with videos of her resuming hiking and running outdoors. She was considered by many to be the Poster Girl for Tollovid, and many others tried Tollovid based on her experience.
She gave some of her supply to others and then ran out herself. She experienced pretty significant resurgence of her symptoms and ended up in ER. Todos rushed her more Tollovid when this was reported, and her issues cleared up once again as soon as back on Tollovid.
She took Gromwell Root during this time but failed to inform Todos. Her agreement with the case study was she would take no other supplements. Then one of her liver biomarkers in a blood test showed decline since her previous blood test a year earlier, and she blamed Tollovid. Went off on a wild rant and blamed Todos. Her account left out key parts that Gerald later provided after she blocked him and deleted her rant posts.
Working on posting all this soon, but so many threads it's hard to keep it all organized where it makes sense. Some of the timelines of posts may be a little skewed because Gerald was responding to multiple threads veering off from the main thread. I think it's important for investors to understand the company's side of events. None of those were deleted.
Market Data 
Markets 
AI
